Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/22/2026

1. SPY
2. WBD
3. PSKY
4. NVDA
5. TSLA
6. USO
7. AMD
8. META
9. AMC
10. COHR

Go back to Pacira BioSciences Advances PCRX-201 Development Program with Successful Transition to Scalable Commercial Manufacturing Process
PACIRA (NASDAQ: PCRX) Delayed: 24.11 -0.58 (2.35%)
Previous Close $24.69    52 Week High $80.25 
Open $24.79    52 Week Low $30.25 
Day High $24.99    P/E N/A 
Day Low $23.98    EPS $-2.08 
Volume 375,530